HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influence of charge on the inactivation of membrane bound (Na+ + K+)-ATPase of Yoshida sarcoma cells by inhibitor proteins from cobra venom.

Abstract
Inactivation of (Na+ + K+)-ATPase of Yoshida sarcoma cells and beef brain microsomes by phospholipase A2 and a cytotoxin P6 from snake venom has been examined in relation to their activity to degrade phospholipids. Cytotoxin P6 which was most basic and devoid of phospholipase activity was most effective in inhibiting the (Na+ + K+)-ATPase of Yoshida sarcoma cells. Phospholipase A2 from Naja naja which was most active in degrading phospholipids was least effective in inhibiting (Na+ + K+)-ATPase in Yoshida sarcoma cells or in beef brain microsomes. Addition of trace amounts of cytotoxin P6 to the phospholipase considerably enhanced the inactivation of (Na+ + K+)-ATPase. The evidence suggests that the charge of the inhibitor protein and its specific structure play an important role in the inactivation of (Na+ + K+)-ATPase.
AuthorsA Zaheer, S S Iyer, B M Braganca
JournalCancer biochemistry biophysics (Cancer Biochem Biophys) Vol. 3 Issue 3 Pg. 123-7 ( 1979) ISSN: 0305-7232 [Print] England
PMID233302 (Publication Type: Journal Article)
Chemical References
  • Elapid Venoms
  • Fatty Acids
  • Phosphatidylcholines
  • Phospholipids
  • Phospholipases
  • Phospholipases A
  • Phospholipases A2
  • Sodium-Potassium-Exchanging ATPase
Topics
  • Animals
  • Cell Membrane (enzymology)
  • Elapid Venoms (pharmacology)
  • Fatty Acids (analysis)
  • Mice
  • Phosphatidylcholines
  • Phospholipases (pharmacology)
  • Phospholipases A (pharmacology)
  • Phospholipases A2
  • Phospholipids (analysis)
  • Sarcoma, Yoshida (enzymology)
  • Sodium-Potassium-Exchanging ATPase (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: